Neurology:偏头痛,偏头痛残疾,创伤和性别少数群体个体的歧视

2022-09-02 Naomi MedSci原创

近日,一项发表在Neurology上的研究发现,偏头痛在性和/或性别少数(SGM)成年人样本中很常见。既往创伤和歧视经历与偏头痛残疾增加有关。精神病合并症在这种关系中发挥重要作用。

近日,一项发表在Neurology上的研究试图描述,在性和/或性别少数(SGM)成年人样本中,偏头痛的频率和严重程度,并检查创伤、歧视和偏头痛相关残疾之间的关系。

研究人员在2018年8月至10月的“身份和平等差异的人口研究”中对 SGM 人群进行了横向研究研究。主要的暴露是任何创伤或歧视,不管归因。根据偏头痛残疾评估(MIDAS)问卷评分≥11,主要结果为中重度偏头痛残疾。研究人员还进行了描述性分析,将有偏头痛的受访者与没有偏头痛的受访者进行比较。多变量 Logit模型研究了创伤/歧视和偏头痛残疾之间的关系,首先控制了社会人口学和临床因素,然后控制了精神病合并症。

结果:

  • 在3325名受访者中,1126名(33.9%)通过 ID-偏头痛标准筛选出偏头痛阳性。大多数偏头痛患者自我报告中度(n = 768,68.2%)或严重(n = 253,22.5%)强度。
  • MIDAS 评分中位数为11(四分差[ IQR ]5-25)。大多数偏头痛患者(n = 1055,93.7%)报告有创伤或歧视史。
  • 在未经调整的分析中,暴露于创伤和歧视与较高的中重度残疾几率相关(OR 1.76,95% CI 1.34-2.32)。
  • 在调整了自我报告的焦虑、抑郁和创伤后心理压力紧张综合症的精神病合并症后,这种关联失去了统计学意义。

结论: 偏头痛在该SGM 成年人样本中很常见,以前的创伤和歧视经历与偏头痛残疾增加有关。该研究结果表明,精神病合并症在这种关系中发挥重要作用,确定了SGM 患者偏头痛残疾的一个潜在的可改变的危险因素。 。

文献来源:Rosendale N, Guterman EL, Obedin-Maliver J, et al. Migraine, Migraine Disability, Trauma, and Discrimination in Sexual and Gender Minority Individuals [published online ahead of print, 2022 Jul 11]. Neurology. 2022;10.1212/WNL.0000000000200941. doi:10.1212/WNL.0000000000200941

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2023-01-18 xjy13

    #群体#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-10-12 yinhl1978

    #Neurol#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-09-03 ms920641618706883

    #创伤#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-09-03 ms8888626721583891

    #歧视#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-09-02 ms9000001538267476

    讲的真好,很受益

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-09-02 屋顶瞄爱赏月

    签到学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1717095, encodeId=65b71e1709529, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Wed Jan 18 11:29:44 CST 2023, time=2023-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001930, encodeId=71942001930f2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Oct 12 13:29:44 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335415, encodeId=db6e133541588, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616532, encodeId=cc2c161653268, content=<a href='/topic/show?id=51bf6334ec1' target=_blank style='color:#2F92EE;'>#歧视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63347, encryptionId=51bf6334ec1, topicName=歧视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e81f19767924, createdName=ms8888626721583891, createdTime=Sat Sep 03 07:29:44 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242778, encodeId=15481242e78d6, content=讲的真好,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55908251951, createdName=ms9000001538267476, createdTime=Fri Sep 02 11:34:36 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242738, encodeId=b79a1242e3859, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Sep 02 09:56:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242735, encodeId=00941242e35a6, content=好文章,值得一读。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Sep 02 09:41:50 CST 2022, time=2022-09-02, status=1, ipAttribution=)]
    2022-09-02 yangchou

    好文章,值得一读。

    0

相关威廉亚洲官网

HAEMOPHILIA:直接抗病毒药物时代血友病患者肝细胞癌的患病率和危险因素:一项全国住院患者样本研究

肝细胞癌(HCC)是慢性丙型肝炎病毒(HCV)感染的主要并发症。尽管DAAs广泛使用,HCV仍然是血友病人群HCC的主要危险因素。

JAHA:静脉血栓栓塞后肺动脉高压的发生率和危险因素

在这一项大型的真实世界的VTE人群中,3.5%的患者在最初的VTE事件发生后的2年内发生PH。随着年龄的增长,在发生静脉血栓栓塞事件时有其他合并症的女性中,风险较高。

JAHA:智能手机记录的步数与心血管危险因素变化的关联

在大型日本成年人中,智能手机多年记录的步数与心血管疾病风险因素的有益变化相关,在关联上男性和女性存在一些差异。

吸烟、饮酒和肥胖,是癌症致死三大帮凶!全球癌症负担报告

报告指出,这些危险因素导致了全球450万例癌症死亡,占癌症死亡的44.4%。

我国近六成心血管病可预防!大数据揭示 12 类可改变危险因素:不健康饮食对女性影响更大,吸烟是男性死亡的首位归因危险因素

研究指出,中国心血管疾病新发和死亡人数中,大约六成与可改变的危险因素有关,其中代谢危险因素和教育程度低占到了近一半以上。

控制七大因素,可防六成房颤!高血压是重要的危险因素

高血压对房颤的影响更大,房颤可通过改善生活方式预防,保持健康的体重、戒烟、戒酒、积极进行身体活动等是预防房颤的重要途径。

拓展阅读

医学界新突破!北京中医药大学发布:芎芍止痛颗粒调节缓解大鼠偏头痛

本研究深入探究了芎芍止痛颗粒治疗偏头痛的作用机制,揭示了其通过调节TRPV1 介导的 NLRP3 炎症通路,抑制神经炎症反应,从而发挥良好的镇痛效果。

好文推荐 | 以患者为中心的角度全面认识偏头痛

若想实现全面有效降低偏头痛的疾病负担,就应对临床表现复杂多变的偏头痛予以全面的新认识,才可能提高公众对偏头痛的知晓就率、重视程度和长期动态管理。

偏头痛:规范防治需从您我做起!

偏头痛是高致残神经系统疾病,我国诊断率低。2025 年患者版威廉亚洲博彩公司 涵盖诊治与管理,助患者自查,强调规范治疗以降低并发症风险。

JAMA Neurology:瑞玛奈珠单抗显著改善偏头痛合并重度抑郁患者的症状及生活质量

尽管针对钙调神经肽(CGRP)通路的单克隆抗体显示在偏头痛预防中疗效显著,但其在合并精神共病患者中的应用数据仍不足。本研究旨在填补此空白,明确瑞玛奈珠单抗对偏头痛和重度抑郁双重症状的影响。

偏头痛的“克星”找到了!北京中医药大学揭秘:芎芍止痛颗粒调节TRPV1介导的NLRP3炎症通路缓解大鼠偏头痛

研究深入探究了芎芍止痛颗粒治疗偏头痛的作用机制,揭示了其通过调节TRPV1 介导的 NLRP3 炎症通路发挥治疗作用的奥秘。

Stroke:年轻隐源性缺血性卒中的"隐形杀手"——高危卵圆孔未闭患者的风险因素解析​

尽管被冠以"隐源性"之名,这类卒中背后往往隐藏着可干预的风险因素网络。

偏头痛医疗质量控制指标中国专家共识(第一版)

中国研究型医院学会(CRHA,Chinese Research Hospital Association) · 2025-08-07

2025 ACP临床威廉亚洲博彩公司 :门诊急性发作性偏头痛的药物治疗

美国医师协会(ACP,American College of Physicians) · 2025-03-18